PTLA
Portola Pharmaceuticals, Inc.
PTLA
PTLA
Delisted
PTLA was delisted on the 1st of July, 2020.
180 hedge funds and large institutions have $1.92B invested in Portola Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 51 increasing their positions, 49 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
20% more funds holding
Funds holding: 150 → 180 (+30)
4% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 49
Holders
180
Holding in Top 10
6
Calls
$39.4M
Puts
$19.4M
Top Buyers
| 1 | +$158M | |
| 2 | +$43.7M | |
| 3 | +$34M | |
| 4 |
FAM
Fred Alger Management
New York
|
+$28.6M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$24.9M |
Top Sellers
| 1 | -$126M | |
| 2 | -$34.4M | |
| 3 | -$32M | |
| 4 |
Morgan Stanley
New York
|
-$22.2M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$15.4M |